ShanghaiMedicilonInc., Shanghai, 201299, China.
College of Animal Science and Technology, Shihezi University, Shihezi, 832003, China.
Sci Rep. 2024 Aug 22;14(1):19537. doi: 10.1038/s41598-024-70579-0.
Porcine epidemic diarrhea virus (PEDV) is a serious disease that poses a significant threat to the pig industry. This study focused on analyzing the Spike protein of PEDV, which harbors crucial antigenic determinants, in identifying dominant epitopes. Immunoinformatics tools were used to screen for B-cell, CD4+ and CD8+ predominance epitopes. These epitopes were then connected to the N-terminal of ferritin to form a self-assembled nanoparticle vaccine. Various physical and chemical properties of the candidate vaccine were analyzed, including secondary structure prediction, tertiary structure modeling, molecular docking, immune response simulation and computer cloning. The results demonstrated that the candidate vaccine was antigenic, soluble, stable, non-allergic, and formed a stable complex with the target receptor TLR-3. Immune simulation analysis showed that the candidate vaccine effectively stimulated both cellular and humoral reactions, leading to increased related cytokines production. Furthermore, efficient and stable expression of the candidate vaccine was achieved through reverse translation in the Escherichia coli K12 expression system following codon optimization and in silico cloning. The developed nanoparticle candidate vaccine in this study holds promise as an effective PEDV vaccine candidate, offering a new approach for the research, development and improvement of vaccines targeting porcine enteric diarrhea coronavirus.
猪流行性腹泻病毒(PEDV)是一种严重的疾病,对养猪业构成重大威胁。本研究专注于分析 PEDV 的 Spike 蛋白,该蛋白包含关键的抗原决定簇,用于鉴定优势表位。免疫信息学工具用于筛选 B 细胞、CD4+和 CD8+优势表位。然后将这些表位连接到铁蛋白的 N 端,形成自组装纳米颗粒疫苗。对候选疫苗的各种物理和化学性质进行了分析,包括二级结构预测、三级结构建模、分子对接、免疫反应模拟和计算机克隆。结果表明,候选疫苗具有抗原性、可溶性、稳定性、非过敏性,并与靶受体 TLR-3 形成稳定的复合物。免疫模拟分析表明,候选疫苗有效地刺激了细胞和体液反应,导致相关细胞因子的产生增加。此外,通过对大肠杆菌 K12 表达系统进行密码子优化和计算机克隆的反向翻译,实现了候选疫苗的高效和稳定表达。本研究中开发的纳米颗粒候选疫苗有望成为一种有效的 PEDV 疫苗候选物,为针对猪肠道冠状病毒的疫苗研究、开发和改进提供了一种新方法。